Press Releases

N3D Unveils the Next Generation of 3D Cell Culturing System

Only days after Rainbow BioSciences closed a deal to acquire an equity interest in Nano3D Biosciences, n3D announced the release of its groundbreaking new 24-well Bio-Assembler. The new device is the latest iteration of n3D’s Bio-Assembler...

Rhenovia launches drug discovery programs in rare, orphan and neglected neurodegenerative diseases

Rhenovia Pharma, a leading biotech company in biosimulation applied to the discovery of new medications to treat neurodegenerative, neurological and psychiatric diseases, announces today that it has initiated drug research programs in rare, orphan and neglected diseases. ...

AstraZeneca files lawsuit against the FDA for decision regarding quetiapine product labelling and exclusivity

AstraZeneca today filed a lawsuit against the US Food and Drug Administration (FDA) in the US District Court for the District of Columbia to overturn the FDA’s denial on 7 March 2012 of Citizen Petitions filed by AstraZeneca...

Boehringer Ingelheim expands capabilities in biopharmaceutical process science

Ingelheim, Germany – Boehringer Ingelheim has expanded its biopharmaceutical development and manufacturing capabilities at its cell culture and microbial sites in Biberach, Germany and in Vienna, Austria. These expansions will enhance state-of-the art cell line...

Cytheris announces results of phase II study indicating that recombinant Interleukin-7 (CYT107) expands CD4 T-cells in gut mucosa of chronically HIV infected immunological non-responder...

Cytheris SA, a clinical stage biopharmaceutical company focused on development of new therapies for immune modulation, announces today results of a multi-center phase II study designed to investigate the potential of recombinant human Interleukin-7 therapy to reconstitute CD4 T-cells...

CiToxLAB increases inhalation test capabilities in North America and Europe

CiToxLAB, a leading CRO in the field of non-clinical research, announces today that it has increased its inhalation test capabilities in North America and Europe. The demand for studies to assess the safety of pharmaceuticals and chemicals via...

Almac expands in US with addition of Commercial Packaging facility in Almac Group

Having identified a business need in the US for a flexible and high quality commercial packaging service provider, the Pharma Services business unit of Almac is proud to expand its established commercial packaging operations with a $10m investment...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read